HopeStage
Back to all studies
RecruitingNCT07679321

Anxiety, depression, asthma medication response and flare-up risk

About this titleRead the official source — NCT07679321
Observational studyAges 14+China
The study in practice

Understand this study

Who could participate?

Listed age limits: from 14 years.

Listed locations
ChangshaSee all locations and recruitment

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: December 1, 2024
Recruitment status
Recruiting
Enrollment listed in the registry
256
Sponsor
Xiangya Hospital of Central South University
Sponsor type
University
Study type
Observational
Intervention type
Other
Locations
China
Age range
Over 14 Years
Official registry ID
NCT07679321
Official title
Show the full official title

The Impact of Anxiety/Depression on the Efficacy of Asthma Control Drugs and the Construction of a Predictive Model for the Risk of Acute Asthma Attacks

Recruitment & locations

Currently recruiting

Changsha

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Xiangya Hospital of Central South University, a university.

Who can participate?

Listed age limits: from 14 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies